Abstract: A pixel array formed on a substrate mainly including scan lines and data lines is provided. The scan lines and the data lines are essentially consisted of conductive patterns disposed at different layers and contact windows electrically connected with the conductive patterns disposed at the different layers. The scan lines and the data lines are respectively consisted of conductive patterns to prevent the scan lines and the data lines from cracking when the substrate is warped. Besides, the pixel array further includes dielectric layers having trenches therein, to divide the dielectric layers into independent dielectric patterns. Thus, the dielectric layers would not crack easily when the substrate is warped.

Abstract: Provided is an optical connection apparatus for a parallel optical interconnect module and a parallel optical interconnect module using the same for reducing a coupling loss generated due to an alignment error when coupled with an optical fiber, comprising: a 2D reflector in a prism shape and having at least two rows of cylinder type lens attached thereto; a 2D optical waveguide having at least two layers of core arrays; at least two rows of 2D optical benches; and a 2D ferrule capable of loading at least two layers of optical fibers so as to facilitate the fixing of the 2D optical waveguide for optical interconnection.

Abstract: Functional fluoro-monomers are polymerized with an organoborane functional initiator in the presence of oxygen to yield functional fluoropolymers and copolymers to produce functional polymers having functional groups at the beginning of the polymer chain.

Abstract: Wireless tags with a plurality of non-equivalent current pathways altered to collectively represent encoded information, each of which responds differently to an interrogation signal. The element is subjected to a signal stimulating the current pathways, each of which contributes to an overall element response. The information may be recovered from the salient features of this overall response. These salient features include resonant frequency, amplitude, relative peak position, relative peak amplitude, damping, and Q factor.

Abstract: A number of cDNA clones whose products may interact with D1 receptors in vivo were identified. One of the clones, P24, was characterized further. P24 is localized in dendrites and spines of pyramidal cells in PFC. The extent of overlap between P24 expressing and D1 receptor expressing pyramidal cells appeared to be 100%. In contrast, only a limited number D1 receptor antibody labeled neurons in caudate expressed P24. P24 lowers the threshold of D1 receptor response to dopamine (DA) by an order of magnitude. Sequence similarity suggests P24 is a diverged member of the RAMP family. The P24 protein is therefore referred to as a D1 DA RAMP, calcyon. The isolated protein and nucleotide molecule encoding the protein, as well as primers for the nucleotide, are described. The protein and compounds modifying DA binding to the receptor or calcium release which is mediated by the Calcyon, are useful in research studies, drug screening, and therapeutically.

Abstract: The invention provides diagnostic procedures wherein the presence or absence of a cell-proliferating disorder, e.g., a breast cancer, may be determined. The imaging agents of the invention include alpha-fetoprotein hydrophilic analogs which have been determined to target cancers, e.g., breast cancer, and are also anti-cell proliferating in nature. These modulators contain amino acid structures which are arranged as a hydrophilic analog of an alpha-fetoprotein. The modulator may be a peptide; a peptidomimetic; or may be in the form of a pharmaceutically acceptable scaffold, such as a polycyclic hydrocarbon to which is attached the necessary amino acid structures. The imaging agents of the invention further comprise an imaging moiety that allows for the imaging of the area targeted by the imaging agent.

Abstract: A negative resistance field-effect element that is a negative differential resistance field-effect element capable of achieving negative resistance at a low power supply voltage (low drain voltage) and also enabling securement of a high PVCR is formed on its InP substrate 11 having an asymmetrical V-groove whose surface on one side is a (100) plane and surface on the other side is a (011) plane with an InAlAs barrier layer (12) that has a trench (TR) one of whose opposed lateral faces is a (111) A plane and the other of which is a (331) B plane. An InGaAs quantum wire (13) that has a relatively narrow energy band gap is formed at the trench bottom surface as a high-mobility channel. An InAlAs modulation-doped layer (20) having a relatively wide energy band gap is formed on the quantum wire as a low-mobility channel.

Abstract: The invention relates to polynucleotides of the PAPAP gene, polypeptides encoded by the PAPAP gene, and antibodies directed specifically against such polypeptides. The invention also concerns methods for the treatment or diagnosis of schizophrenia, bipolar disorder or related CNS disorder. The invention also concerns the interaction of PAPAP with schizophrenia candidate gene g34872.

Abstract: Disclosed herein is a method of optically producing a clock, in which clock components are extracted from the spectrum of a transmitted optical signal and the influence of noise and jitter on the extracted clock components is reduced, thus improving the stability of an optical communication system. In the clock producing method of the present invention, a plurality of clock components are extracted by filtering out frequency bands between neighboring intensity peaks, and then a clock having reduced noise and jitter is produced by logically ANDing two or more of the plurality of clock components extracted at the step of extracting the plurality of clock components.

Abstract: An OLED device having pillars, wherein the pillars serve to pattern a conductive layer during deposition. The profile of the pillars covers the edges of at least one functional layer to protect it from exposure to potentially deleterious substances.

Abstract: The invention features a method of treating an inflammatory condition in an individual, comprising administering an agent that inhibits the interaction between a Toll-like receptor 2 (TLR2) and a high mobility group B (HMGB) polypeptide to the individual. The invention also features methods for identifying agents that inhibit the interaction between TLR2 and HMGB.

Abstract: There are disclosed various processes, apparatuses and systems for treating a halogen-containing gas such as F2 that involve generating a plasma in order to reduce chemically the halogen-containing gas into products that are more environmentally manageable. According to a particular embodiment, a reducing agent is mixed with the halogen-containing gas to produce a feed gas mixture and a non-thermal plasma is generated in the feed gas mixture in the presence of liquid water. According to another embodiment, a vaporized portion of a liquid reducing agent is mixed with the halogen-containing gas to produce a reaction mixture and a non-thermal plasma is generated in the reaction gas mixture to reduce the halogen-containing gas.

Abstract: Unsintered poly(tetrafluoroethylene) resin feeds are treated with ionizing radiation in an absorbed dose of no more than 1,000 Gy at room temperature in air so that only the melting temperature of the resin feeds is shifted toward the lower end without changing the quantities of heat of fusion and crystallization.

Abstract: The present invention is directed to a molecule comprising a polypeptide having substantial homology with a CTL epitope selected from the group consisting of ADLMGYIPLV (Core131-140; SEQ ID NO:1), LLALLSCLTV (Core178-187; SEQ ID NO:2), QLRRHIDLLV (SEQ ID NO:55), LLCPAGHAV (NS31169-1177; SEQ ID NO:26), KLVALGINAV (NS31406-1415; SEQ ID NO:28), SLMAFTAAV (NS41789-1797; SEQ ID NO:34), LLFNILGGWV (NS41807-1816; SEQ ID NO:35), and ILDSFDPLV (NS52252-2260; SEQ ID NO:42). Such molecules are used for the treatment and prevention of acute or chronic HCV hepatitis; suitable pharmaceutical compositions and methods using such compositions are disclosed.

Abstract: Glucose oxidase enzymes are provided, including novel variants of galactose oxidase enzymes. The polynucleotides that encode these novel variants can be expressed in recombinant host cell expression systems. The novel variant oxidase enzymes are capable of oxidizing compounds towards which wild-type galactose oxidase (e.g. D-galactose: oxygen 6-oxidoreductase, GAO; EC 1.1.3.9) has little or no activity. Preferred galactose oxidase variants are those which that have improved capability to oxidize secondary alcohols and/or D-glucose relative to the wild-type enzyme.

Abstract: A method for calculating frequency offset using arc tangent calculations according to real part and imaginary part input values received externally. The method includes converting arc tangent equations for determining frequency offset into equations to perform log calculations; calculating frequency offset using linear approximation and the converted log equations; and dividing the real part input value to bit values of a predetermined size to realize a size similar to that of the imaginary part input value if a range of the frequency offset value to be calculated is small. With the use of the method, hardware area and power consumption may be reduced, and precise frequency offset may be calculated.

Abstract: The present invention provides universal transfer apparatus and method to use this universal transfer apparatus. This invention further provides a method to obtain speciation data for organometals in a complex matrix, such as cigarette smoke. Our data demonstrate that gas chromatography linked to inductively coupled plasma mass spectrophotometer with the universal transfer apparatus provides metal speciation information for samples of tobacco smoke. The organometals include lead, tin, arsenic and cadmium.

Abstract: A tube and float system for use in separation and axial expansion of the buffy coat includes a transparent or semi-transparent, flexible sample tube and a rigid separator float having a specific gravity intermediate that of red blood cells and plasma. The float includes a main body portion of reduced diameter to provide a clearance gap between the inner wall of the sample tube and the float. One or more protrusions on the main body portion serve to support the flexible tube. During centrifugation, the centrifugal force causes the diameter of the flexible tube to expand and permit density-based axial movement of the float in the tube. The float further includes a pressure relief system to alleviate pressure build up in the trapped red blood cell blood fraction below the float, thereby preventing red blood cells from being forced into the annular gap containing the buffy coat layers.

Abstract: A pharmaceutical composition for topical administration comprising an analgesic effective amount of a peptide comprising L-amino acids of the formula (I): pGLU-X—Y-Z M (I) and a pharmaceutically acceptable excipient. X is an amino acid selected from the group consisting of GLY, VAL, GLU, ASP, SER, ALA, ASN, GLN, ILE, LEU, PRO, LYS and ARG, Y is TRP or THR, and Z is any L-amino acid, or Z is null. When Z is any L-amino acid, one but not both of Y and Z is TRP, and when Z is null, Y=TRP. An alkyl group may be attached to an amino acid of the peptide. Also disclosed are the peptide, the preparation of the pharmaceutical composition and a topical method of treating or preventing pain in a mammal.

Abstract: A new and distinct floricane fruiting variety of red raspberry, named ‘Moutere’, botanically identified as Rubus idaeus L. is described. The new variety is distinguished from others by its early season high yields of attractive, uniform sized, large, bright red berries. The plant exhibits a semi spine-free upright growth habit, of strong vigor. The fruit are suitable for consumption as early season high-grade fresh berries and are very attractive when packaged for the fresh market. In addition, the plant has displayed resistance to Raspberry Bushy Dwarf Virus (RBDV) under New Zealand conditions.